[Form 4] Lite Strategy, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lite Strategy, Inc. (LITS) reported that a non-employee director received a customary annual stock option grant. On 11/14/2025, the director was awarded options to purchase 55,000 shares of common stock at an exercise price of $2.02 per share as compensation for board service. The options vest over one year, with 16.66666% vesting on the grant date and the remaining options vesting in equal monthly amounts beginning 12/14/2025 and continuing through 11/14/2026. The options expire on 11/14/2035 and are held directly by the reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flynn James P

(Last) (First) (Middle)

C/O LITE STRATEGY, INC.

9920 PACIFIC HEIGHTS BLVD., SUITE 150

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ LITS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.02	11/14/2025		A		55,000		(1)	11/14/2035	Common Stock	55,000	(2)	55,000	D

Explanation of Responses:

1. Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.

2. Received as compensation for service on the Board.

	/s/ Justin J. File, as Attorney-in-fact for the Reporting Person	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lite Strategy, Inc. (LITS) disclose?

Lite Strategy, Inc. disclosed that a non-employee director received a stock option grant for 55,000 shares of common stock at an exercise price of $2.02 per share on 11/14/2025.

What is the vesting schedule for the 55,000 Lite Strategy (LITS) stock options?

For the 55,000 options, 16.66666% vest on the 11/14/2025 grant date. The remaining options vest in equal monthly amounts from 12/14/2025 through 11/14/2026.

What is the exercise price and expiration date of the Lite Strategy (LITS) director stock options?

The director’s stock options have an exercise price of $2.02 per share and an expiration date of 11/14/2035.

Why did the Lite Strategy (LITS) director receive 55,000 stock options?

The director received the 55,000 stock options as customary annual compensation for serving on the company’s board of directors.

Is the Lite Strategy (LITS) director’s stock option holding reported as direct or indirect ownership?

The filing reports the 55,000 stock options as being held with direct ownership by the reporting person.